Last reviewed · How we verify

NCT03423420

Pontos-Central Venous Pressure and Cardiac Surgery

Completed Last updated 25 July 2019
What this trial tests

trial in Central Venous Pressure in 5,945 participants. Completed in 31 December 2013.

Timeline
1 January 2006
Primary endpoint
31 December 2013
31 December 2013

Quick facts

Lead sponsorCharite University, Berlin, Germany
StatusCompleted
Study typeOBSERVATIONAL
Enrollment5,945
Start date1 January 2006
Primary completion31 December 2013
Estimated completion31 December 2013
Sites1 location across Germany

Conditions studied

Sponsor

Charite University, Berlin, Germany

Who can join

18 and older, any sex, with Central Venous Pressure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Recent studies indicated the central venous pressure (CVP) as a prognostic marker. Therefore, we retrospectively analyzed the CVP on admission to the intensive care unit (ICU) in cardiac surgery patients regarding its prognostic value for morbidity and mortality.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. High Central Venous Pressure after Cardiac Surgery Might Depict Hemodynamic Deterioration Associated with Increased Morbidity and Mortality.
    Schiefenhövel F, Trauzeddel RF, Sander M, Heringlake M, et al · · 2021 · cited 12× · PMID 34501390 · DOI 10.3390/jcm10173945

Verify or expand the search:

Other recruiting trials for Central Venous Pressure

Currently open trials in the same condition.

Other Charite University, Berlin, Germany trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03423420.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing